Steven M. Albelda, M.D.,vice chief, Pulmonary, Allergy, and Critical Care Division, director of Lung Research and director, Thoracic Oncology Laboratories at the University of Pennsylvania School of Medicine, has received the prestigious Wagner Medal for Excellence in Mesothelioma Research from the International Mesothelioma Interest Group (IMIG). The award was presented at the 2010 IMIG International Conference in Kyoto, Japan.
The Wagner Medal is the highest honor presented by IMIG to a leader in the field and is only awarded every two years. The award was created in honor of J. Christopher Wagner, who was a leader in the field of mesothelioma and made major contributions to the understanding of mesothelioma, its cause, and the goals for prevention. By his clinical observations and animal studies, he was the first to establish that mesothelioma was caused by asbestos.
Dr. Albelda has been a member of the Penn Medicine community since 1975 when he enrolled in the University of Pennsylvania School of Medicine. His clinical and research interests are primarily in thoracic oncology with a goal of developing novel approaches to the treatment of lung cancer and mesothelioma.
For more information on the award and IMIG, visit http://imig.org/.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.